Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility |
|
Incidental lymphopenia and mortality: a prospective cohort study |
|
Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
|
Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study |
|
Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population |
|
Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population |
|
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
|
Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer |
|
Is high vitamin B12 status a cause of lung cancer? |
|
Is smoking heaviness causally associated with alcohol use? A Mendelian randomization study in four European cohorts |
|
JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing |
|
Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats. |
|
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
|
Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
|
Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
|
Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis |
|
Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals |
|
Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer |
|
Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
|
Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer. |
|
Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
|
Molecular characterisation of the rare translocation t(5;11)(q31;q23) identifies a novel MLL partner gene a candidate tumor suppressor gene of acute myeologenous leukemia on chromosome 5q31 |
|
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
|
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
|
No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype |
|
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
|
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
|
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
|
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
|
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
|
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
|
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
|
Physical activity and risk of instant and 28-day case-fatality in myocardial infarction |
|
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
|
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
|
Prediction and clinical utility of a contralateral breast cancer risk model |
|
Prediction of breast cancer risk based on profiling with common genetic variants |
|
Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival |
|
Protein-altering germline mutations implicate novel genes related to lung cancer development |
|
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
|
RAD51B in Familial Breast Cancer |
|
Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia |
|
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
|
Reply from Authors re: Andrew J. Vickers, Michael J. Pencina. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol 2013;64:394-6: prostate-specific antigen velocity: new unscreened cohort, na |
|
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
|
Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor status |
|
Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. |
|
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
|
Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study. |
|
The role of genetic breast cancer susceptibility variants as prognostic factors |
|
Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases |
|
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
|
Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study |
|
Shared heritability and functional enrichment across six solid cancers |
|
Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals. |
|
Shorter leukocyte telomere length is associated with higher risk of infections: a prospective study of 75,309 individuals from the general population |
|
Smoking and Increased White and Red Blood Cells |
|
Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people |
|
SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
|
Statin use and reduced cancer-related mortality |
|
Telomere length and depression: prospective cohort study and Mendelian randomisation study in 67 306 individuals. |
|
Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart |
|
Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm |
|
TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals |
|
Transcriptome-wide association study reveals candidate causal genes for lung cancer |
|
Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population |
|
Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study |
|
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants |
|
YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies. |
|